전체 < 기사목록 - 히트뉴스

편집. 2025-11-26 11:10 (수)

한국어

ENG

中文

にほんご

Korea’s Big Three Reshape the Global Obesity Drug Market
바이오 Sodam Park reporter 11.11 06:11
Lawmakers Sound Alarm Over Obesity Drug Use in Children
입법 Sodam Park reporter 10.27 04:55
AI Helps Hanmi Cut Obesity Drug Development Time by Half
제약 Sodam Park reporter 10.27 04:55
Eli Lilly to Launch Mounjaro in Korea on August 21
제약 Sodam Park reporter 08.16 06:00
ABL Bio Pushes Ahead in Cancer Trials, Eyes 2026 Breakthrough
바이오 Sodam Park reporter 08.13 06:12
Obesity Race Heats Up—K-Bio Gains Edge with Fewer Side Effects
바이오 Sodam Park reporter 07.31 04:50
Hanmi, D&D, LigaChem to Reveal Key Pipeline Data in H2
바이오 Sodam Park reporter 07.28 04:52
Wegovy's Momentum Stalls in Just Three Months
제약 Sodam Park reporter 02.28 11:16
Novo Nordisk’s Wegovy Shows Cardiovascular Benefits Beyond Weight Loss
제약 Sodam Park reporter 02.03 04:07
Surge in Illegal Marketing of Obesity Drug Wegovy Raises Concerns
소비자 Sodam Park reporter 01.10 08:47
2024 Boldest Biotech M&A Deals: Top Moves by Big Pharma
외신 Sodam Park reporter 2024.12.31 22:31
Celltrion BioSolutions Debuts: $2.1 Billion Revenue Target by 2031
바이오 Sodam Park reporter 2024.12.19 04:54
Battle for South Korea's Obesity Market: Wegovy vs. Mounjaro
제약 Sodam Park reporter 2024.11.19 04:45
Obesity Drug, Wegovy, Monitored for Ad Claims, Side Effects
입법 Sodam Park reporter 2024.10.30 04:56
GI-102 Monotherapy Shows Strong Results in ESMO 2024 Interview
제약 Sodam Park reporter 2024.09.27 04:39
Kwangdong Pharma: Growth via Imports and First Generics, Clear R&D Vision
제약 Sodam Park reporter 2024.07.29 11:10
South Korean Companies Race to Develop Oral GLP-1 Obesity Drugs
바이오 Sodam Park reporter 2024.07.26 05:56
LG Chem’s Pharma Q1 Sales Up 2.5% to $207mn
바이오 Sodam Park reporter 2024.05.04 09:20
Dong-A ST, STGen Bio, ST Pharm's Triangular Partnership at Songdo Bio Hub
제약 Sodam Park reporter 2024.03.14 06:01
Inventage Lab Nears Korean L/O for Long-Acting Diabetes, Obesity Treatment
바이오 Sodam Park reporter 2024.01.05 06:00

상단영역

본문영역

obesity treatment 목록 ( 총 : 25건)

기사목록 보기 형태

Korea’s Big Three Reshape the Global Obesity Drug Market

Lawmakers Sound Alarm Over Obesity Drug Use in Children

AI Helps Hanmi Cut Obesity Drug Development Time by Half

Eli Lilly to Launch Mounjaro in Korea on August 21

ABL Bio Pushes Ahead in Cancer Trials, Eyes 2026 Breakthrough

Obesity Race Heats Up—K-Bio Gains Edge with Fewer Side Effects

Hanmi, D&D, LigaChem to Reveal Key Pipeline Data in H2

Wegovy's Momentum Stalls in Just Three Months

Novo Nordisk’s Wegovy Shows Cardiovascular Benefits Beyond Weight Loss

Surge in Illegal Marketing of Obesity Drug Wegovy Raises Concerns

2024 Boldest Biotech M&A Deals: Top Moves by Big Pharma

Celltrion BioSolutions Debuts: $2.1 Billion Revenue Target by 2031

Battle for South Korea's Obesity Market: Wegovy vs. Mounjaro

Obesity Drug, Wegovy, Monitored for Ad Claims, Side Effects

GI-102 Monotherapy Shows Strong Results in ESMO 2024 Interview

Kwangdong Pharma: Growth via Imports and First Generics, Clear R&D Vision

South Korean Companies Race to Develop Oral GLP-1 Obesity Drugs

LG Chem’s Pharma Q1 Sales Up 2.5% to $207mn

Dong-A ST, STGen Bio, ST Pharm's Triangular Partnership at Songdo Bio Hub

Inventage Lab Nears Korean L/O for Long-Acting Diabetes, Obesity Treatment